查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1412717

顱內支架市場：按類型、應用和最終用戶分類 - 全球預測 2024-2030

Intracranial Stents Total Addressable Market by Type (Balloon Expanding Stents, Self-Expanding Stents, Stent-Assisted Coil Embolization), Application (Brain Aneurysm, Intracranial Stenosis), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年顱內支架市場規模為29.2億美元，預計2024年將達30.4億美元，2030年將達到42.8億美元，複合年成長率為5.61%。

全球顱內支架市場

主要市場統計
基準年[2023] 29.2億美元
預測年份 [2024] 30.4億美元
預測年份 [2030] 42.8億美元
複合年成長率（%） 5.61%
顱內支架市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估顱內支架市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對顱內支架市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-顱內支架市場規模及預測是多少？

2-顱內支架市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-顱內支架市場的技術趨勢和法律規範是什麼？

4-顱內支架市場主要供應商的市場佔有率為何？

5-進入顱內支架市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球顱內疾病盛行率不斷上升
      • 人們對微創顱內手術的興趣日益濃厚
      • 提高診斷率
    • 抑制因素
      • 顱內支架手術相關的副作用
    • 機會
      • 研究機構的新臨床試驗和研究
      • 持續的產品開發和改進
    • 任務
      • 缺乏合格和熟練的專業人員
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章顱內支架市場：依類型

  • 球囊擴張型支架
  • 自動擴張型支架
  • 支架輔助彈簧圈栓塞

第7章顱內支架市場：依應用分類

  • 腦動脈瘤
  • 顱內狹窄

第8章顱內支架市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第9章 北美及南美顱內支架市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區顱內支架市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東及非洲顱內支架市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Acandis GmbH
    • Johnson & Johnson Services, Inc.
    • Medtronic PLC
    • MicroPort Scientific Corporation
    • optimed Medizinische Instrumente GmbH
    • Sino Medical Sciences Technology Inc.
    • Stryker Corporation
    • Terumo Corporation
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-742BD517FF34

[183 Pages Report] The Intracranial Stents Total Addressable Market size was estimated at USD 2.92 billion in 2023 and expected to reach USD 3.04 billion in 2024, at a CAGR 5.61% to reach USD 4.28 billion by 2030.

Global Intracranial Stents Total Addressable Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.04 billion
Forecast Year [2030] USD 4.28 billion
CAGR (%) 5.61%
Intracranial Stents Total Addressable Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Stents Total Addressable Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Stents Total Addressable Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Stents Total Addressable Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic PLC, MicroPort Scientific Corporation, optimed Medizinische Instrumente GmbH, Sino Medical Sciences Technology Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Stents Total Addressable Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Balloon Expanding Stents
    • Self-Expanding Stents
    • Stent-Assisted Coil Embolization
  • Application
    • Brain Aneurysm
    • Intracranial Stenosis
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intracranial Stents Total Addressable Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Stents Total Addressable Market?

3. What are the technology trends and regulatory frameworks in the Intracranial Stents Total Addressable Market?

4. What is the market share of the leading vendors in the Intracranial Stents Total Addressable Market?

5. Which modes and strategic moves are suitable for entering the Intracranial Stents Total Addressable Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intracranial Stents Total Addressable Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of intracranial disease across the globe
      • 5.1.1.2. Rising preference for minimally invasive intracranial surgeries
      • 5.1.1.3. Increase in number of diagnostic rates
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse effects of intracranial stents surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging clinical trials and studies by research organizations
      • 5.1.3.2. Ongoing product development and enhancement
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of qualified and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intracranial Stents Total Addressable Market, by Type

  • 6.1. Introduction
  • 6.2. Balloon Expanding Stents
  • 6.3. Self-Expanding Stents
  • 6.4. Stent-Assisted Coil Embolization

7. Intracranial Stents Total Addressable Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Aneurysm
  • 7.3. Intracranial Stenosis

8. Intracranial Stents Total Addressable Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Intracranial Stents Total Addressable Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Stents Total Addressable Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Stents Total Addressable Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Acandis GmbH
    • 13.1.3. Johnson & Johnson Services, Inc.
    • 13.1.4. Medtronic PLC
    • 13.1.5. MicroPort Scientific Corporation
    • 13.1.6. optimed Medizinische Instrumente GmbH
    • 13.1.7. Sino Medical Sciences Technology Inc.
    • 13.1.8. Stryker Corporation
    • 13.1.9. Terumo Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET DYNAMICS
  • FIGURE 7. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET LICENSE & PRICING